Table 1 shows the up-to-date knowledge about some representative products targeting the CD40-CD154 axis for therapeutics of autoimmune disorders, including autoimmune arthritis. The authors also recommend the excellent review by Karnell et al. [90]. The gene discussed is CD40LG; the disease is autoimmune disease.